Archive for
May, 2010
Monday, May 17th, 2010
Although Genentech is still seen by oncologists and hematologists as the company with the best overall image, that lead has been challenged by Novartis Oncology, according to a study by the strategic consulting firm Market Strategies International.
The company's syndicated study identifies which companies are perceived by oncologists and hematologists to ...
Posted in
Med Ad News, Sales & Marketing, Sales force effectiveness |
No Comments »
Tuesday, May 11th, 2010
DDMAC's workload is about to get a lot steeper.
Mark Senak of Eye on FDA broke the news on Twitter that FDA has launched a new program, the "Truthful Drug Advertising and Promotion Ad Program," or the "Bad Ad Program." Ed Silverman, AKA Pharmalot, also reports on it here.
"The Bad Ad ...
Posted in
Uncategorized |
No Comments »
Thursday, May 6th, 2010
On May 6, thousands of individuals gathered on the 3rd floor of the New York Hilton in Manhattan for the 2010 "HBA Woman of the Year" Luncheon, which honored many of the healthcare industry's rising stars. What a rush and honor to be in the presence of such a dynamic ...
Posted in
Uncategorized |
No Comments »
Thursday, May 6th, 2010
Med Ad News’ 19th annual report on the Top 100 Biotechnology Companies in our upcoming June issue will explore the impact of U.S. healthcare reform legislation on the biotech industry. Of particular note for the industry is a provision establishing the therapeutic discovery project tax credit.
The bill provides up to ...
Posted in
Legal actions, R&D Directions |
No Comments »
Tuesday, May 4th, 2010
Sanofi-Aventis U.S., the marketer of Lantus SoloSTAR, has created the “Choose” campaign as a way to generate a dialogue about insulin among people with type 2 diabetes and their healthcare providers. The campaign, which just launched and will continue throughout the year, includes print advertisements, television spots, and an online ...
Posted in
Adwise |
No Comments »
|
|
